The Patent Finder

Gemin X Pharmaceuticals Canada Inc.

Also on record
Records under this name other than patents Gemin X Pharmaceuticals Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Gemin X Pharmaceuticals Canada Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,211,912Compositions and Methods for Effecting Nad+ Levels Using a Nicotinamide Phosphoribosyl Tranferase Inhibitor
Lapsed on the fee record
Ended Jul 3, 2024 · Medium confidence
Lapsed on the fee recordEnded Jul 3, 2024Medium confidence
US 8,173,677Compositions and Methods for Effecting Nad+ Levels Using a Nicotinamide Phosphoribosyl Transferase Inhibitor
Lapsed on the fee record
Ended May 8, 2024 · Medium confidence
Lapsed on the fee recordEnded May 8, 2024Medium confidence
US 8,420,638Triheterocyclic Compounds and Compositions Thereof
Lapsed on the fee record
Ended Apr 16, 2021 · High confidence
Lapsed on the fee recordEnded Apr 16, 2021High confidence
US 8,420,693Dipyrrole Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Lapsed on the fee record
Ended Apr 16, 2021 · High confidence
Lapsed on the fee recordEnded Apr 16, 2021High confidence
US 7,425,553Triheterocyclic Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Lapsed on the fee record
Ended Sep 16, 2020 · High confidence
Lapsed on the fee recordEnded Sep 16, 2020High confidence
US 6,407,244Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
Term ended
Term ended Jan 26, 2020 · USPTO record
Term endedTerm ended Jan 26, 2020USPTO record
US 6,602,879Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Term ended
Ended no later than Jan 26, 2020 · Low confidence
Term endedEnded no later than Jan 26, 2020Low confidence
US 7,491,745Pyrrole-Type Compounds, Compositions and Methods for Treating Cancer or Viral Disease
Term ended
Term ended Jan 26, 2020 · Medium confidence
Term endedTerm ended Jan 26, 2020Medium confidence
US 7,144,912Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer, Treating Viral Diseases and Causing Immunosuppression
Lapsed on the fee record
Ended Dec 5, 2018 · High confidence
Lapsed on the fee recordEnded Dec 5, 2018High confidence
US 7,709,477Methods for Treating Cancer
No holder on record
Lapsed on the fee record
Ended May 4, 2018 · High confidence
Lapsed on the fee recordEnded May 4, 2018High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited